tiprankstipranks
Medical Ikkou Group Co., Ltd. (JP:3353)
:3353
Japanese Market
3353
Medical Ikkou Group Co., Ltd.
RESEARCH TOOLSreports

Medical Ikkou Group Co., Ltd. (3353) Ratios

1 Followers

Medical Ikkou Group Co., Ltd. Ratios

JP:3353's free cash flow for Q2 2025 was ¥0.11. For the 2025 fiscal year, JP:3353's free cash flow was decreased by ¥ and operating cash flow was ¥0.02. See a summary of the company’s cash flow.
Ratios
TTM
Feb 26Feb 25Feb 24Feb 23
Liquidity Ratios
Current Ratio
 1.65 1.65 1.54 1.61 1.78
Quick Ratio
 1.44 1.44 1.35 1.44 1.61
Cash Ratio
 0.53 0.53 0.58 0.74 0.86
Solvency Ratio
 0.10 0.10 0.10 0.10 0.11
Operating Cash Flow Ratio
 0.00 0.10 0.10 0.41 0.18
Short-Term Operating Cash Flow Coverage
 0.00 0.43 0.31 1.16 0.46
Net Current Asset Value
¥ -2.09B¥ -2.09B¥ -1.55B¥ -1.10B¥ -1.66B
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.29 0.30 0.33
Debt-to-Equity Ratio
 0.66 0.66 0.71 0.72 0.76
Debt-to-Capital Ratio
 0.40 0.40 0.42 0.42 0.43
Long-Term Debt-to-Capital Ratio
 0.32 0.32 0.30 0.30 0.33
Financial Leverage Ratio
 2.40 2.40 2.43 2.39 2.28
Debt Service Coverage Ratio
 0.66 0.66 0.44 0.51 0.57
Interest Coverage Ratio
 17.40 17.40 26.50 28.86 18.41
Debt to Market Cap
 0.94 0.89 1.19 1.06 0.92
Interest Debt Per Share
 2.78K 2.78K 2.69K 2.56K 2.44K
Net Debt to EBITDA
 1.61 1.61 1.33 0.75 1.21
Profitability Margins
Gross Profit Margin
11.57%11.57%11.58%11.41%9.39%
EBIT Margin
3.25%3.25%3.50%4.30%4.03%
EBITDA Margin
4.79%4.79%5.07%6.27%6.51%
Operating Profit Margin
3.25%3.25%3.50%3.91%2.76%
Pretax Profit Margin
3.68%3.68%3.93%4.17%3.88%
Net Profit Margin
2.32%2.32%2.34%2.61%2.24%
Continuous Operations Profit Margin
2.39%2.39%2.37%2.71%2.28%
Net Income Per EBT
62.97%62.97%59.59%62.54%57.82%
EBT Per EBIT
113.24%113.24%112.39%106.63%140.48%
Return on Assets (ROA)
3.40%3.40%3.31%3.28%2.76%
Return on Equity (ROE)
8.59%8.16%8.04%7.85%6.30%
Return on Capital Employed (ROCE)
6.90%6.90%7.50%7.34%4.66%
Return on Invested Capital (ROIC)
4.04%4.04%3.87%4.07%2.40%
Return on Tangible Assets
3.49%3.49%3.41%3.38%2.92%
Earnings Yield
11.71%11.11%13.70%11.67%7.81%
Efficiency Ratios
Receivables Turnover
 6.57 6.57 6.47 6.59 6.77
Payables Turnover
 7.56 7.56 7.05 7.22 8.93
Inventory Turnover
 20.59 20.59 19.31 20.17 25.01
Fixed Asset Turnover
 5.04 5.04 4.82 4.38 3.54
Asset Turnover
 1.47 1.47 1.41 1.26 1.23
Working Capital Turnover Ratio
 7.65 7.95 7.67 6.59 5.68
Cash Conversion Cycle
 24.96 24.96 23.52 22.94 27.64
Days of Sales Outstanding
 55.52 55.52 56.41 55.41 53.91
Days of Inventory Outstanding
 17.73 17.73 18.90 18.10 14.60
Days of Payables Outstanding
 48.28 48.28 51.80 50.57 40.87
Operating Cycle
 73.24 73.24 75.32 73.51 68.51
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 320.94 318.70 1.14K 348.08
Free Cash Flow Per Share
 0.00 58.44 53.54 1.05K 255.58
CapEx Per Share
 0.00 262.51 265.16 86.24 92.49
Free Cash Flow to Operating Cash Flow
 0.00 0.18 0.17 0.92 0.73
Dividend Paid and CapEx Coverage Ratio
 0.00 0.89 1.01 9.02 2.63
Capital Expenditure Coverage Ratio
 0.00 1.22 1.20 13.20 3.76
Operating Cash Flow Coverage Ratio
 0.00 0.12 0.12 0.45 0.14
Operating Cash Flow to Sales Ratio
 0.00 0.02 0.02 0.11 0.04
Free Cash Flow Yield
0.00%1.92%2.43%44.37%9.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 8.54 9.00 7.30 8.57 12.80
Price-to-Sales (P/S) Ratio
 0.20 0.21 0.17 0.22 0.29
Price-to-Book (P/B) Ratio
 0.70 0.73 0.59 0.67 0.81
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 52.19 41.09 2.25 10.13
Price-to-Operating Cash Flow Ratio
 0.00 9.50 6.90 2.08 7.44
Price-to-Earnings Growth (PEG) Ratio
 0.48 0.73 0.82 0.23 -1.18
Price-to-Fair Value
 0.70 0.73 0.59 0.67 0.81
Enterprise Value Multiple
 5.75 5.97 4.70 4.31 5.62
Enterprise Value
 15.13B 15.72B 11.55B 10.79B 12.40B
EV to EBITDA
 5.75 5.97 4.70 4.31 5.62
EV to Sales
 0.28 0.29 0.24 0.27 0.37
EV to Free Cash Flow
 0.00 71.48 57.36 2.73 12.92
EV to Operating Cash Flow
 0.00 13.02 9.64 2.52 9.48
Tangible Book Value Per Share
 4.08K 4.08K 3.65K 3.45K 2.96K
Shareholders’ Equity Per Share
 4.15K 4.15K 3.75K 3.52K 3.21K
Tax and Other Ratios
Effective Tax Rate
 0.35 0.35 0.40 0.35 0.41
Revenue Per Share
 14.60K 14.61K 12.87K 10.62K 9.02K
Net Income Per Share
 338.57 338.74 301.35 276.71 202.20
Tax Burden
 0.63 0.63 0.60 0.63 0.58
Interest Burden
 1.13 1.13 1.12 0.97 0.96
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.08 0.08 0.07 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 0.95 1.06 2.57 1.00
Currency in JPY